FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

NCT00293670 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

573

Enrollment

OTHER

Sponsor class

Conditions

Patients With T1-4 Advanced Prostate Cancer

Interventions

DRUG: Goserelin (Zoladex)

Sponsor

Tampere University

Collaborators

[object Object]